by Csequence | Aug 11, 2022 | Communications, Weekly Cannabis News
August 5th – August 12th, 2022 Cannabis Use & COVID-19 Symptoms Severity COVID-19 cannabis consumers reported better clinical outcomes compared to non-consumers, suggesting the need for additional investigations. The novel severe acute respiratory syndrome...
by Csequence | Aug 9, 2022 | Communications, Journal Club, Podcast
Discussion around the effects of a cannabinoid receptor 1 antagonist on THC-induced vascular inflammation Please join us for a conversation about a study published in 2022 in the Journal Cell entitled: “Cannabinoid receptor 1 antagonist genistein attenuates...
by Csequence | Aug 8, 2022 | Communications, Journal Club, Podcast
Discussion around survey results behind cannabis use during pregnancy Please join us for a conversation about a study published in 2022 in the Journal of Cannabis Research entitled: “Factors that shape pregnant women’s perceptions regarding the safety of cannabis use...
by Csequence | Aug 8, 2022 | Communications, Journal Club, Podcast
Discussion around the anti-COVID-19 potential of different cannabis extracts in reducing inflammation Please join us for a conversation about a study published in 2022 in the journal Cell Death Discovery entitled: “New AKT-dependent mechanisms of anti-COVID-19 action...
by Csequence | Aug 5, 2022 | Communications, Weekly Cannabis News
Menopause, Anxiety Disorders, and Nociception: Weekly Cannabis News July 29th-August 5th, 2022
by Csequence | Aug 4, 2022 | Communications, Journal Club
Discussion around the potential use of cannabis oil administration as a treatment to reduce seizure frequency. Please join us for a conversation about a study published in 2021 in the journal BMJ Pediatrics Open entitled: “Medical cannabis for severe treatment...
Some text her explaining our event planning services.
For more info, contact us:
events@csequence.com